Category IP-Watch Briefs

Citizens’ Summit Contra CETA: It’s Not Only Wallonia

With the vote on the European Union-Canada trade agreement (CETA) on the agenda once more at the upcoming EU Council meeting tomorrow the representatives of European and Canadian cities and regions gathered at Brussels today for a “CETA Citizens' Summit.” Gerardo Pisarello, vice mayor of the city of Barcelona, said that cities like his see CETA as a barrier to their plans to remunicipalize water and energy services and the attempts “to open up public procurement to small companies and cooperatives."

WHO Pandemic Influenza Advisory Group Meeting In Secret This Week

The World Health Organization pandemic influenza framework advisory group is meeting this week, behind closed doors. A consultation is expected to take place on 20 October with stakeholders, and an information session has been organised on 21 October on the work of the advisory group, but no press is allowed in either meeting nor able to obtain any information about any aspect of the week’s events.

55 Civil Society Groups Ask US Government To Allow Export Of Affordable Version Of Prostate Cancer Drug Xtandi

A range of 55 civil society organisations from around the world today sent a letter asking the United States Department of Health and Human Services to accept an offer from a Canadian generics company, Biolyse Pharma, to manufacture and export high-priced cancer drug Xtandi to countries with a per capita income of less than one-third that of the United States.

WIPO Conference Archive Missing Video Critical Of Artificial Intelligence, Social Media Giants

This morning at the World Intellectual Property Organization General Assemblies, WIPO Director General Francis Gurry commented on the success of the WIPO Conference on the Global Digital Content Market, which took place in April. But the full video of the keynote speaker, who had sharp words for corporate internet giants and other new technologies, is missing from the archive.

Survey Finds Promising Future, Major Challenges For Augmented And Virtual Reality

Optimism is said to exist about the future of augmented reality (AR) and virtual reality (VR) following a survey completed by over 650 respondents in the industry. Though growth and investment are anticipated, concerns about a lack of compelling content and cost and issues with the user experience were among the survey’s key findings. Legal risks were identified as well, with the highest percentage relating to technology and intellectual property licensing.